相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatic fibrosis: 2022 Unmet needs and a blueprint for the future
Scott L. Friedman et al.
HEPATOLOGY (2022)
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
Anshika Jangra et al.
CELLS (2022)
Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (&x6276;(sic)(sic)&x7600;(sic)) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial
Zheng-xin Li et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2021)
STAT3: A key regulator in liver fibrosis
Jie Zhao et al.
ANNALS OF HEPATOLOGY (2021)
Scientometric analysis of vital pulp therapy studies
K. Kodonas et al.
INTERNATIONAL ENDODONTIC JOURNAL (2021)
Anti-fibrotic treatments for chronic liver diseases: The present and the future
Naoshi Odagiri et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
Mapping the knowledge domain of the evolution of emergy theory: a bibliometric approach
Xiumei Xu et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain
Yi Qin et al.
BRAIN RESEARCH BULLETIN (2020)
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula
Hui Li
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen et al.
CELLS (2020)
Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis
Joeri Lambrecht et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019)
Lixin Ke et al.
FRONTIERS IN PHARMACOLOGY (2020)
Novel biomarkers for the management of chronic hepatitis B
Takako Inoue et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Visualizing a field of research: A methodology of systematic scientometric reviews
Chaomei Chen et al.
PLOS ONE (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index
Jacqueline A. Bachofner et al.
LIVER INTERNATIONAL (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Knowledge Domain and Emerging Trends in Organic Photovoltaic Technology: A Scientometric Review Based on CiteSpace Analysis
Fengjun Xiao et al.
FRONTIERS IN CHEMISTRY (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Science Mapping: A Systematic Review of the Literature
Chaomei Chen
JOURNAL OF DATA AND INFORMATION SCIENCE (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
DIABETOLOGIA (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Antifibrotic Therapies: Where Are We Now?
Young Joon Yoon et al.
SEMINARS IN LIVER DISEASE (2016)
Hepatic Fibrosis: Emerging Therapies
Scott L. Friedman
DIGESTIVE DISEASES (2015)
XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4
Shu-fang Jin et al.
EXPERIMENTAL CELL RESEARCH (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Hepatic fibrosis: Concept to treatment
Christian Trautwein et al.
JOURNAL OF HEPATOLOGY (2015)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Sciatic nerve injury repair: a visualized analysis of research fronts and development trends
Guangyao Liu et al.
NEURAL REGENERATION RESEARCH (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial
Jianhui Qu et al.
TRIALS (2014)
Patterns of Connections and Movements in Dual-Map Overlays: A New Method of Publication Portfolio Analysis
Chaomei Chen et al.
JOURNAL OF THE ASSOCIATION FOR INFORMATION SCIENCE AND TECHNOLOGY (2014)
Evolving therapies for liver fibrosis
Detlef Schuppan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Evolving challenges in hepatic fibrosis
Scott L. Friedman
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Software survey: VOSviewer, a computer program for bibliometric mapping
Nees Jan van Eck et al.
SCIENTOMETRICS (2010)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
B. J. Veldt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Assessment of hepatic fibrosis with magnetic resonance elastography
Meng Yin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
John P. Iredale
JOURNAL OF CLINICAL INVESTIGATION (2007)
HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C
K Patel et al.
HEPATOLOGY (2006)
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets
A. M. Gressner et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B
Ping Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Searching for intellectual turning points: Progressive knowledge domain visualization
CM Chen
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
